GLOW 70mg
GLOW is a multi-compound research formulation developed for laboratory investigation of synergistic cellular and connective tissue–related pathways. This blend contains:
• GHK-Cu (50mg) – a copper-binding peptide complex studied for its interaction with extracellular matrix regulation, cellular signaling, and antioxidant pathways.
• BPC-157 (10mg) – a synthetic peptide fragment evaluated in research models for its involvement in connective tissue biology and gastrointestinal structural integrity pathways.
• TB-500 (10mg) – a synthetic fragment of Thymosin Beta-4 investigated for its role in actin regulation, cellular migration signaling, and tissue remodeling processes.
Preclinical research has explored the combined interaction of these compounds in models focused on:
• Connective tissue signaling mechanisms
• Cellular repair–associated pathways
• Extracellular matrix regulation
• Inflammatory signaling balance
Available findings remain preliminary and dependent on study design, dosing framework, and experimental conditions.